MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology

Go back to MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
(NYSE: VATE) Delayed: 7.39 -0.2 (2.64%)
Previous Close $7.59    52 Week High
Open $7.59    52 Week Low
Day High $7.68    P/E N/A 
Day Low $7.37    EPS
Volume 11,573